Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-313.02%Cash Return on Invested Capital
VS
Market
Sector
Industry
History
$ 2.07Close
$ 0.25 - $ 3.64 52-Week Range
Ticker Information
Ticker
RLMDCompany Name
RELMADA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQRELMADA THERAPEUTICS INC - Cash Return on Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RLMD - CROIC Historical data
| Date | Cash Return on Invested Capital | Free Cash Flow | Invested Capital |
|---|---|---|---|
| 6/30/2025 | -313.02% | $ -49.92M | $ 15.95M |
| 3/31/2025 | -253.05% | $ -56.79M | $ 22.44M |
| 12/31/2024 | -145.7% | $ -51.76M | $ 35.52M |
| 9/30/2024 | -111.72% | $ -53.21M | $ 47.63M |
| 6/30/2024 | -78.35% | $ -48.18M | $ 61.49M |
| 3/31/2024 | -66.89% | $ -48.19M | $ 72.05M |
| 12/31/2023 | -60.52% | $ -51.66M | $ 85.36M |
| 9/30/2023 | -76.73% | $ -77.29M | $ 100.73M |
| 6/30/2023 | -83.1% | $ -92.52M | $ 111.34M |
| 3/31/2023 | -80.4% | $ -100.88M | $ 125.47M |
Key Performance Insights, Last 5 Years
- RELMADA THERAPEUTICS INC's latest trailing twelve months (TTM) CROIC stands at -20.26%.
- Over the past 5 years, RELMADA THERAPEUTICS INC's average CROIC has been -88.82%.
- The median CROIC for RELMADA THERAPEUTICS INC during this period was -70.4%
- RELMADA THERAPEUTICS INC reached its highest CROIC over the past 5 years at -20.26%.
- The lowest CROIC recorded by RELMADA THERAPEUTICS INC in the same timeframe -313.02%
Similar metrics to Inv. Capital:
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Invested Capital - [Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Capital Expenditures Margin - [Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Cash Return on Invested Capital
[Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].FCF / Inv. Capital
(=) CROIC CROIC for RELMADA THERAPEUTICS INC is calculated as follows: FCF [ $ -24.76M ] / Inv. Capital [ $ 122.21M ]
(=) CROIC [ -20.26% ] RLMD - Cash Return on Invested Capital, Last 5 years
-313.02%
Minimum
Jun 30, 2025
-20.26%
Maximum
Sep 30, 2020
-88.82%
Average
-70.4%
Median
CROIC Benchmark AnalysisMarket
The chart above depicts the distribution of CROIC for companies in the Total Stock Market. The average CROIC of the companies is 2.81% with a standard deviation of 15%.
The following table provides additional summary stats:
CROIC in the Market:
| filtered constituents | 3.46K |
|---|---|
| min | -43.7% |
| max | 49.3% |
| average | 2.81% |
| median | 4.99% |
| std | 15% |